自治医科大学附属さいたま医療センター

診療科のご案内

後期専門研修を希望される方へ

専門研修プログラムのご案内

教育目標 呼吸器専門医の育成
当センターは、日本内科学会、日本呼吸器学会、日本呼吸器内視鏡学会等の研修認定施設です。研修によりそれぞれの学会の専門医が取得できます。
3年目まで 当院の内科専門研修プログラムに従って呼吸器内科、総合診療科、救急部などをローテーションし、内科専門医を取得します。
呼吸器内科ローテート中は、病棟勤務、外来診療、気管支鏡検査、肺機能検査、病理検査等を行いながら呼吸器内科専門医取得のための並行研修を受けます。
4年目まで 呼吸器内科専門医を取得します。
5年目以降 学位取得、国内留学が選択できます。

後期専門研修申込方法等について

当院呼吸器内科では、胸部悪性腫瘍や間質性肺疾患の症例を非常に多く経験できます。各分野を専門とする医師もそろっていて、診療科全体あるいはチーム内で活発な議論を重ねて診療しています。
特に担当医として経験できる胸部悪性腫瘍の症例数は県下でも随一と思います。
上記のプログラム以外に、短期の研修につても随時相談に応じます。お気軽にご連絡ください。

呼吸器内科教授　山口 泰弘  yamayasu@jichi.ac.jp  までご連絡ください。

カンファレンス・連絡会

レジデント向けの胸部レントゲン写真読影会 適宜開催しています
呼吸器内科、呼吸器外科、薬剤部との合同カンファレンス 毎週水曜日

研究実績（2019年以降）

  • Nishihara-Kato F, Imai H, Tsuda T, Wasamoto S, Nagai Y, Kashikawa T, Miura Y, Ono A, Yamada Y, Masubuchi K, Osaki T, Nakagawa J, Umeda Y, Minemura H, Kozu Y, Taniguchi H, Ohta H, Kaira K, Kagamu H. Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel. Oncology 102:30-42, 2024.
  • Watanabe S, Furuya N, Nakamura A, Shiihara J, Nakachi I, Tanaka H, Nakao M, Minato K, Seike M, Sasaki S, Kisohara A, Takeuchi S, Honda R, Takamura K, Kagamu H, Yoshimura K, Kobayashi K, Kikuchi T.A. phase Ⅱ study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study). Eur J Cancer 197:113469, 2024.
  • Yamaguchi O, Mori K, Takata S, Shibata K, Chikamori K, Kimura N, Nagai Y, Nakagawa T, Igawa S, Harada T, Yoshioka H, Tanaka H, Nogawa H, Satoh H, Shiozawa T, Tsuji K, Kobayashi K, Kaira K. Extended ICI treatment after first-line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non-small lung cancer. Thorac Cancer 15:163-171, 2024.
  • Nomura M, Yuzawa M, Hiruta M, Ohta H. Acute respiratory failure developing in a patient with lymphomatoid granulomatosis. BMJ Case Rep. 16:e255697, 2023.
  • Yamaguchi Y, Okochi J, Urano T, Ebihara T, Kadono T, Arai H, Iijima K, Ishii S, Kuzuya M, Rakugi H, Akishita M, Higashi K, Kozaki K. Survey on the health status within two weeks after mRNA vaccination for SARS-CoV-2 in geriatric health service facilities in Japan. Geriatr Gerontol Int. 23:892-893, 2023.
  • Masuda K, Nagai Y, Amari H, Tahara H, Maeda Y, Shiihara J, Ohta H, Hiruta M, Yamaguchi Y. Hyperprogressive disease in lung metastases without target lesion progression after durvalumab consolidation therapy: A case report.Thorac Cancer. 14:3161-3165, 2023.
  • Imai H, Wasamoto S, Tsuda T, Nagai Y, Kishikawa T, Masubuchi K, Osaki T, Miura Y, Umeda Y, Ono A, Minemura H, Yamada Y, Nakagawa J, Kozu Y, Taniguchi H, Ohta H, Kasai T, Kaira K, Kagamu H. Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed. Thorac Cancer. 14:2567-2578, 2023.
  • Tsuda T, Imai H, Nagai Y, Umeda Y, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Ishizuka T, Taniguchi H, Kagamu H. Intermittent administration of atezolizumab with combined carboplatin and etoposide therapy for patients with extensive disease small cell lung cancer. Oncol Lett. 25(3):111, 2023.
  • Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H. Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer. Front Oncol. 12:1080729, 2023.
  • Shiono A, Imai H, Wasamoto S, Tsuda T, Nagai Y, Minemura H, Yamada Y, Kishikawa T, Umeda Y, Takechi H, Yamaguchi O, Mouri A, Kaira K, Taniguchi H, Minato K, Kagamu H. Real-world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive-disease small-cell lung cancer. Cancer Med. 12:73-83, 2023.
  • Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K. Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival. Thorac Cancer. 13:2776-2785, 2022.
  • Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H. Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer. Invest New Drugs. 40:1066-1079, 2022.
  • Nagai Y, Sata M, Ohta H, Onuki T, Saito T, Uchiyama A, Kurosaki A, Yoshizumi N, Takigami A, Nakazawa S, Nakayama M, Yamaguchi H, Hagiwara K. Herpes zoster in patients with lung cancer treated with PD-1/PD-L1 antibodies. Immunotherapy. 14:1211-1217, 2022.
  • Yamanaka T, Kidana K, Yamaguchi Y, Hirahara S, Hirakawa Y, Mizuki M, Arai H, Akishita M, Miura H. Palliative home care for older patients with respiratory disease in Japan: Practices and opinions of physicians. Geriatr Gerontol Int. 22:943-949, 2022.
  • Goto Y, Miura H, Yamaguchi Y, Onishi J. Evaluation of an advance care planning training program for practice professionals in Japan incorporating shared decision making skills training: a prospective study of a curricular intervention. BMC Palliat Care. 21:135, 2022.
  • Nomura M, Ohta H, Minegishi K, Akimoto M, Hamamoto K, Yamaguchi Y.　Spouting Chylothorax in Gorham-Stout DiseaseAm J Respir Crit Care Med. 205:e53-e54, 2022.
  • Okamoto S, Ishii M, Hibi S, Akishita M, Yamaguchi Y. Breathing irregularities before sleep onset on polysomnography in patients with heart diseases. Sleep Breath. 26:605-612, 2022.
  • Yamaguchi Y, Saif-Ur-Rahman KM, Nomura M, Ohta H, Hirakawa Y, Yamanaka T, Hirahara S, Miura H. Opioid Prescription Method for Breathlessness Due to Non-Cancer Chronic Respiratory Diseases: A Systematic Review. Int J Environ Res Public Health. 19:4907, 2022.
  • Mizushina Y, Shiihara J, Nomura M, Ohta H, Ohyanagi F, Morishita Y, Tsubochi H, Tanaka A, Yamaguchi Y. Immunoglobulin G4-related Pleuritis Complicated with Minimal Change Disease. Intern Med. 61: 723-728, 2022.
  • Ishii M, Yamaguchi Y, Hamaya H, Iwata Y, Takada K, Ogawa S, Imura M, Akishita M. Influence of oral health on frailty in patients with type 2 diabetes aged 75 years or older. BMC Geriatr. 22:145, 2022.
  • Fujita K, Nakayama M, Sata M, Nagai Y, Hisata S, Mato N, Suzuki T, Bando M, Hizawa N, Hagiwara K:Highly sensitive detection of driver mutations from cytological samples and cfDNA in lung cancer. Cancer Med. 10: 8595-8603, 2021.
  • Hamaya H, Hamada S, Ishii M, Kojima T, Okochi J, Akishita M, Yamaguchi Y. Use of drugs for the management of chronic respiratory diseases at intermediate care facilities for older adults in Japan. Geriatr Gerontol Int. 21: 1147-1148, 2021.
  • Goto Y, Yamaguchi Y, Onishi J, Arai H, Härter M, Scholl I, Kriston L, Miura H. Adapting the patient and physician versions of the 9-item shared decision making questionnaire for other healthcare providers in Japan. BMC Med Inform Decis Mak. 21: 314, 2021.
  • Yuzawa M, Ohta H, Nomura M, Minegishi K, Oshiro H, Yamaguchi Y. A case of prominent immunoglobulin G4-positive lymphadenopathy in response to microscopic lung cancer. Respirol Case Rep. 9: e0854, 2021.
  • Shiihara J, Ohyanagi F, Amari H, Toda M, Tahara H, Yuzawa M, Maeda Y, Nomura M, Mizushina Y, Nagai Y, Ohta H, Yamaguchi Y. Dramatic response to alectinib in a patient with ALK-rearranged squamous cell lung cancer. Thorac Cancer. 12: 2420-2423, 2021.
  • Mizushina Y, Ohyanagi F, Shiihara J, Nomura M, Ohta H, Oshiro H, Tsubochi H, Kusaka G, Yamaguchi Y. Clinical case of lung spindle cell carcinoma markedly responsive to pembrolizumab. Thorac Cancer. 12: 2279-2282, 2021.
  • Nangaku M, Kadowaki T, Yotsuyanagi H, Ohmagari N, Egi M, Sasaki J, Sakamoto T, Hasegawa Y, Ogura T, Chiba S, Node K, Suzuki R, Yamaguchi Y, Murashima A, Ikeda N, Morishita E, Yuzawa K, Moriuchi H, Hayakawa S, Nishi D, Irisawa A, Miyamoto T, Suzuki H, Sone H, Fujino Y. The Japanese Medical Science Federation COVID-19 Expert Opinion English Version. JMA J. 4: 148-162, 2021.
  • Kuzuya M, Aita K, Katayama Y, Katsuya T, Nishikawa M, Hirahara S, Miura H, Yanagawa M, Arai H, Iijima K, Okochi J, Kozaki K, Yamaguchi Y, Rakugi H, Akishita M: The Japan Geriatrics Society consensus statement "recommendations for older persons to receive the best medical and long-term care during the COVID-19 outbreak-considering the timing of advance care planning implementation". Geriatr Gerontol Int 20: 1112-1119, 2020.
  • Hirakawa Y, Hirahara S, Yamaguchi Y, Yamanaka T, Arai H, Miura H. Improving the quality of community primary palliative care in COPD: A qualitative study of health-care providers. Home Health Care Serv Q. 40: 39-53, 2021.
  • Nomura M, Ohta H, Hiruta M, Kudo F, Ohyanagi F, Yamaguchi Y. Steroid resistance in organizing pneumonia caused by pulmonary cryptococcosis. Respirol Case Rep. 8: e00556, 2020.
  • Ishii M, Yamaguchi Y, Hamaya H, Ogawa S, Imura M, Akishita M. Characteristics of factors for decreased lung function in elderly patients with type 2 diabetes. Sci Rep 9: 20206, 2019.
  • Ogura T, Takigawa N, Tomii K, Kishi K, Inoue Y, Ichihara E, Homma S, Takahashi K, Akamatsu H, Ikeda S, Inase N, Iwasawa T, Ohe Y, Ohta H, Onishi H, Okamoto I, Ogawa K, Kasahara K, Karata H, Kishimoto T, Kitamura Y, Gemma A, Kenmotsu H, Sakashita H, Sakamoto S, Sekine K, Takiguchi Y, Tada Y, Toyooka S, Nakayama Y, Nishioka Y, Hagiwara K, Hanibuchi M, Fukuoka J, Minegishi Y, Yanagihara T, Yamamoto N, Yamamoto H, Gaga M, Fong KM, Powell CA, Kiura K; DLD/TO Assemblies of JRS. Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia. Respir Investig. 57: 512-533, 2019.
  • Shiihara J, Ohta H, Ikeda S, Baba T, Okudera K, Ogura T. Erdheim-Chester disease progression from miliary pulmonary nodules to large tumours. Respirol Case Rep 7: e00475, 2019
  • Mizushina Y, Karasawa T, Aizawa K, Kimura H, Watanabe S, Kamata R, Komada T, Mato N, Kasahara T, Koyama S, Bando M, Hagiwara K, Takahashi M. Inflammasome-Independent and Atypical Processing of IL-1β Contributes to Acid Aspiration-Induced Acute Lung Injury. J Immunol. 203: 236-246, 2019
  • Watanabe T, Yamashita T, Sugawara H, Fukuchi T, Ishii A, Nagai Y, Ohyanagi F, Koyama S, Ushijima J, Takagi K, Tanaka A. Rapid Progression of Lung Cancer Following Emergency Caesarean Section Led to Postpartum Acute Respiratory Failure. Intern Med. 58(7):991-997, 2019
  • Watanabe T, Yamashita T, Sugawara H, Fukuchi T, Ishii A, Nagai Y, Ohyanagi F, Koyama S, Ushijima J, Takagi K, Tanaka A. Rapid Progression of Lung Cancer Following Emergency Caesarean Section Led to Postpartum Acute Respiratory Failure. Intern Med. 58(7):991-997, 2019

―和文原著論文、総説　（一部）

  • 山口泰弘：高齢者のcommon disease 呼吸不全、COPD.日本医師会雑誌 152(10) 1136-1137, 2024
  • 山口泰弘：【高齢者呼吸器疾患-診断・治療の最新動向-】高齢者呼吸器疾患と緩和ケア.日本臨床　81(5) 608-614, 2023
  • 平原佐斗司、山口泰弘、山中崇、平川仁尚、三浦久幸：末期認知症高齢者の肺炎の苦痛に関する系統的レビュー.日本老年医学会雑誌　58(4),610-616,2021
  • 平原佐斗司、山口泰弘、山中崇、平川仁尚、三浦久幸：末期認知症高齢者の肺炎に対する抗菌薬の予後の改善と苦痛緩和の効果に関する系統的レビュー.日本在宅医療連合学会誌 3(1),60-67,2022
  • 山口泰弘：【超高齢社会を支える医学・医療の提案】高齢者疾患の包括的管理　高齢者へのワクチン治療　.医学のあゆみ279(5),520-524,2021
  • 柚木真、山口泰弘：【高齢者の呼吸器疾患】高齢者診療におけるCOPD治療と併存症のマネジメント. Aging & Health 30(2),14-17,2021
  • 山口泰弘：【ますます増える誤嚥性肺炎診療の最前線】びまん性嚥下性細気管支炎とは? 日本医師会雑誌 149(12),2178,2021
  • 太田洋充：【高齢者呼吸器疾患の診断から看取りまで】総説　間質性肺炎up to date. Geriatric Medicine 58(4),285-290, 2020
  • 湯澤基、山口泰弘：【新時代に求められる臨床検査の理解と適正活用】呼吸機能検査の理解と臨床応用（解説/特集）.日本内科学会雑誌109: 2496-2501,2020

学会活動

  • 日本呼吸器学会
  • 日本アレルギー学会
  • 日本内科学会
  • 日本呼吸ケア・リハビリテーション学会
  • 日本呼吸器内視鏡学会
  • 日本肺癌学会
  • アメリカ胸部疾患学会
  • 欧州呼吸器学会

他

ページの先頭へ